LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Health & Fitness
• Education
• Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

pubmed, article, google, scholar, cas, cancer, thyroid, cell, anaplastic, carcinoma, central, azd, resistance, cells, mtor, mtorc, treatment, oncol, inhibitor, paclitaxel, atc, pathways, ptx, target, research, dual, kinase, vivo, clinical, access, inhibitors, privacy, cookies, content, oncology, activity, protein, therapeutic, human, effects, tumor, growth, res, rapamycin, signaling, rev, multidrug, serbia, author, belgrade,

Topics {✒️}

cancer/find-a-clinical-trial/a-trial lung resistance-related protein pi3k-akt-mtor pathway month download article/chapter pi3k/akt/mtor pathways pi3k/pten/akt pathways article  google scholar anaplastic thyroid carcinoma follicular thyroid cancers dramatic antitumor effects miodrag dragoj anaplastic thyroid cancer solid-tumours-tax-torc multidrug resistance proteins atp binding cassette anaplastic tyroid carcinoma medullary thyroid carcinoma papillary thyroid carcinoma chemo-resistant malignancy pi3k-mtor pathways pi3k/akt/mtor targeting ras-mapk-erk chemo-resistance personalized therapy overcome paclitaxel resistance growth signal integration multidrug resistance mediated full article pdf privacy choices/manage cookies phosphatidylinositol 3-kinase/akt p70 s6 kinase refractory indolent lymphoma check access instant access multiple signaling pathways related subjects targeting drug resistance natural products chemistry cancer stem cells human gastric cancer rac1 signaling pathways tubulin-binding agents reduced erk activity p-glycoprotein research nanoemulsion-loaded paclitaxel milica pešić endometrial cancer cells azd2014 versus everolimus author information authors data support results

Questions {❓}

• Weber, Anaplastic thyroid carcinoma: Palliation or treatment?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma
         description:Anaplastic thyroid carcinoma (ATC) is an aggressive, chemo-resistant malignancy. Chemo-resistance is often associated with changes in activity of the RAS/MAPK/ERK and PI3K/AKT/mTOR pathways and/or a high expression of ATP binding cassette (ABC) transporters, such as P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP). To assess the therapeutic efficacy in ATC of a combination of the dual mTOR kinase inhibitor vistusertib (AZD2014) and paclitaxel (PTX), we generated a new cell line (Rho-) via the selection of human thyroid carcinoma 8505C cells that exhibit a low accumulation of rhodamine 123, which serves as a P-gp and BCRP substrate. Immunohistochemistry was used for P-gp and BCRP expression analyses in primary ATC patient samples. Spheroid formation and immunodeficient NSG mice were used for performing in vitro and in vivo tumorigenicity assays, respectively. MTT, flow-cytometry, fluorescent microscopy, cell death and proliferation assays, as well as migration, invasion and gelatin degradation assays, were used to assess the potential of AZD2014 to enhance the effects of PTX. ATC xenografts in SCID mice were used for evaluating in vivo treatment efficacies. Rho- cells were found to be 10-fold more resistant to PTX than 8505C cells and, in addition, to be more tumorigenic. We also found that AZD2014 sensitized Rho- cells to PTX by inhibiting proliferation and by inducing autophagy. The combined use of AZD2014 and PTX efficiently inhibited in vitro ATC cell migration and invasion. Subsequent in vivo xenograft studies indicated that the AZD2014 and PTX combination effectively suppressed ATC tumor growth. Our data support results from recent phase I clinical trials using combinations of AZD2014 and PTX for the treatment of solid tumors. Such combinations may also be employed for the design of novel targeted ATC treatment strategies.
         datePublished:2018-05-22T00:00:00Z
         dateModified:2018-05-22T00:00:00Z
         pageStart:409
         pageEnd:426
         sameAs:https://doi.org/10.1007/s13402-018-0380-x
         keywords:
            Anaplastic thyroid carcinoma
            mTOR
            AZD2014
            Paclitaxel
            Chemo-resistance
            Targeted therapy
            Cancer Research
            Biomedicine
            general
            Pathology
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-018-0380-x/MediaObjects/13402_2018_380_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-018-0380-x/MediaObjects/13402_2018_380_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-018-0380-x/MediaObjects/13402_2018_380_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-018-0380-x/MediaObjects/13402_2018_380_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-018-0380-x/MediaObjects/13402_2018_380_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-018-0380-x/MediaObjects/13402_2018_380_Fig6_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-018-0380-x/MediaObjects/13402_2018_380_Fig7_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-018-0380-x/MediaObjects/13402_2018_380_Fig8_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-018-0380-x/MediaObjects/13402_2018_380_Fig9_HTML.gif
         isPartOf:
            name:Cellular Oncology
            issn:
               2211-3436
               2211-3428
            volumeNumber:41
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Zorica Milošević
               affiliation:
                     name:University of Belgrade
                     address:
                        name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jasna Banković
               affiliation:
                     name:University of Belgrade
                     address:
                        name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jelena Dinić
               affiliation:
                     name:University of Belgrade
                     address:
                        name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chrisiida Tsimplouli
               affiliation:
                     name:University of Thessaly
                     address:
                        name:Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Evangelia Sereti
               affiliation:
                     name:University of Thessaly
                     address:
                        name:Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Miodrag Dragoj
               affiliation:
                     name:University of Belgrade
                     address:
                        name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Verica Paunović
               affiliation:
                     name:University of Belgrade
                     address:
                        name:Institute of Microbiology and Immunology, School of Medicine, University of Belgrade, Belgrade, Serbia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zorka Milovanović
               affiliation:
                     name:Institute for Oncology and Radiology of Serbia
                     address:
                        name:Institute for Oncology and Radiology of Serbia, Belgrade, Serbia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Marija Stepanović
               affiliation:
                     name:University of Belgrade
                     address:
                        name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nikola Tanić
               affiliation:
                     name:University of Belgrade
                     address:
                        name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kostantinos Dimas
               affiliation:
                     name:University of Thessaly
                     address:
                        name:Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Milica Pešić
               url:http://orcid.org/0000-0002-9045-8239
               affiliation:
                     name:University of Belgrade
                     address:
                        name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma
      description:Anaplastic thyroid carcinoma (ATC) is an aggressive, chemo-resistant malignancy. Chemo-resistance is often associated with changes in activity of the RAS/MAPK/ERK and PI3K/AKT/mTOR pathways and/or a high expression of ATP binding cassette (ABC) transporters, such as P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP). To assess the therapeutic efficacy in ATC of a combination of the dual mTOR kinase inhibitor vistusertib (AZD2014) and paclitaxel (PTX), we generated a new cell line (Rho-) via the selection of human thyroid carcinoma 8505C cells that exhibit a low accumulation of rhodamine 123, which serves as a P-gp and BCRP substrate. Immunohistochemistry was used for P-gp and BCRP expression analyses in primary ATC patient samples. Spheroid formation and immunodeficient NSG mice were used for performing in vitro and in vivo tumorigenicity assays, respectively. MTT, flow-cytometry, fluorescent microscopy, cell death and proliferation assays, as well as migration, invasion and gelatin degradation assays, were used to assess the potential of AZD2014 to enhance the effects of PTX. ATC xenografts in SCID mice were used for evaluating in vivo treatment efficacies. Rho- cells were found to be 10-fold more resistant to PTX than 8505C cells and, in addition, to be more tumorigenic. We also found that AZD2014 sensitized Rho- cells to PTX by inhibiting proliferation and by inducing autophagy. The combined use of AZD2014 and PTX efficiently inhibited in vitro ATC cell migration and invasion. Subsequent in vivo xenograft studies indicated that the AZD2014 and PTX combination effectively suppressed ATC tumor growth. Our data support results from recent phase I clinical trials using combinations of AZD2014 and PTX for the treatment of solid tumors. Such combinations may also be employed for the design of novel targeted ATC treatment strategies.
      datePublished:2018-05-22T00:00:00Z
      dateModified:2018-05-22T00:00:00Z
      pageStart:409
      pageEnd:426
      sameAs:https://doi.org/10.1007/s13402-018-0380-x
      keywords:
         Anaplastic thyroid carcinoma
         mTOR
         AZD2014
         Paclitaxel
         Chemo-resistance
         Targeted therapy
         Cancer Research
         Biomedicine
         general
         Pathology
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-018-0380-x/MediaObjects/13402_2018_380_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-018-0380-x/MediaObjects/13402_2018_380_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-018-0380-x/MediaObjects/13402_2018_380_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-018-0380-x/MediaObjects/13402_2018_380_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-018-0380-x/MediaObjects/13402_2018_380_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-018-0380-x/MediaObjects/13402_2018_380_Fig6_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-018-0380-x/MediaObjects/13402_2018_380_Fig7_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-018-0380-x/MediaObjects/13402_2018_380_Fig8_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-018-0380-x/MediaObjects/13402_2018_380_Fig9_HTML.gif
      isPartOf:
         name:Cellular Oncology
         issn:
            2211-3436
            2211-3428
         volumeNumber:41
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Zorica Milošević
            affiliation:
                  name:University of Belgrade
                  address:
                     name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jasna Banković
            affiliation:
                  name:University of Belgrade
                  address:
                     name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jelena Dinić
            affiliation:
                  name:University of Belgrade
                  address:
                     name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chrisiida Tsimplouli
            affiliation:
                  name:University of Thessaly
                  address:
                     name:Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Evangelia Sereti
            affiliation:
                  name:University of Thessaly
                  address:
                     name:Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Miodrag Dragoj
            affiliation:
                  name:University of Belgrade
                  address:
                     name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Verica Paunović
            affiliation:
                  name:University of Belgrade
                  address:
                     name:Institute of Microbiology and Immunology, School of Medicine, University of Belgrade, Belgrade, Serbia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zorka Milovanović
            affiliation:
                  name:Institute for Oncology and Radiology of Serbia
                  address:
                     name:Institute for Oncology and Radiology of Serbia, Belgrade, Serbia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Marija Stepanović
            affiliation:
                  name:University of Belgrade
                  address:
                     name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nikola Tanić
            affiliation:
                  name:University of Belgrade
                  address:
                     name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kostantinos Dimas
            affiliation:
                  name:University of Thessaly
                  address:
                     name:Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Milica Pešić
            url:http://orcid.org/0000-0002-9045-8239
            affiliation:
                  name:University of Belgrade
                  address:
                     name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cellular Oncology
      issn:
         2211-3436
         2211-3428
      volumeNumber:41
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Belgrade
      address:
         name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
         type:PostalAddress
      name:University of Belgrade
      address:
         name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
         type:PostalAddress
      name:University of Belgrade
      address:
         name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
         type:PostalAddress
      name:University of Thessaly
      address:
         name:Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
         type:PostalAddress
      name:University of Thessaly
      address:
         name:Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
         type:PostalAddress
      name:University of Belgrade
      address:
         name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
         type:PostalAddress
      name:University of Belgrade
      address:
         name:Institute of Microbiology and Immunology, School of Medicine, University of Belgrade, Belgrade, Serbia
         type:PostalAddress
      name:Institute for Oncology and Radiology of Serbia
      address:
         name:Institute for Oncology and Radiology of Serbia, Belgrade, Serbia
         type:PostalAddress
      name:University of Belgrade
      address:
         name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
         type:PostalAddress
      name:University of Belgrade
      address:
         name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
         type:PostalAddress
      name:University of Thessaly
      address:
         name:Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
         type:PostalAddress
      name:University of Belgrade
      address:
         name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Zorica Milošević
      affiliation:
            name:University of Belgrade
            address:
               name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
               type:PostalAddress
            type:Organization
      name:Jasna Banković
      affiliation:
            name:University of Belgrade
            address:
               name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
               type:PostalAddress
            type:Organization
      name:Jelena Dinić
      affiliation:
            name:University of Belgrade
            address:
               name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
               type:PostalAddress
            type:Organization
      name:Chrisiida Tsimplouli
      affiliation:
            name:University of Thessaly
            address:
               name:Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
               type:PostalAddress
            type:Organization
      name:Evangelia Sereti
      affiliation:
            name:University of Thessaly
            address:
               name:Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
               type:PostalAddress
            type:Organization
      name:Miodrag Dragoj
      affiliation:
            name:University of Belgrade
            address:
               name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
               type:PostalAddress
            type:Organization
      name:Verica Paunović
      affiliation:
            name:University of Belgrade
            address:
               name:Institute of Microbiology and Immunology, School of Medicine, University of Belgrade, Belgrade, Serbia
               type:PostalAddress
            type:Organization
      name:Zorka Milovanović
      affiliation:
            name:Institute for Oncology and Radiology of Serbia
            address:
               name:Institute for Oncology and Radiology of Serbia, Belgrade, Serbia
               type:PostalAddress
            type:Organization
      name:Marija Stepanović
      affiliation:
            name:University of Belgrade
            address:
               name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
               type:PostalAddress
            type:Organization
      name:Nikola Tanić
      affiliation:
            name:University of Belgrade
            address:
               name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
               type:PostalAddress
            type:Organization
      name:Kostantinos Dimas
      affiliation:
            name:University of Thessaly
            address:
               name:Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
               type:PostalAddress
            type:Organization
      name:Milica Pešić
      url:http://orcid.org/0000-0002-9045-8239
      affiliation:
            name:University of Belgrade
            address:
               name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
      name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
      name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
      name:Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
      name:Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
      name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
      name:Institute of Microbiology and Immunology, School of Medicine, University of Belgrade, Belgrade, Serbia
      name:Institute for Oncology and Radiology of Serbia, Belgrade, Serbia
      name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
      name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
      name:Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
      name:Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(216)

• What's the revenue for https://www.springernature.com/gp/authors?
• What's the monthly income of https://link.springernature.com/home/?
• What's the profit of https://order.springer.com/public/cart?
• What is the monthly revenue of https://submission.nature.com/new-submission/13402/3?
• What's the monthly money flow for https://orcid.org/0000-0002-9045-8239?
• How much revenue does https://www.springernature.com/gp/librarians/licensing/agc/journals produce monthly?
• How much profit does https://doi.org/10.1097%2F00001622-200301000-00012 make?
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Anaplastic%20thyroid%20cancer&journal=Curr.%20Opin.%20Oncol.&doi=10.1097%2F00001622-200301000-00012&volume=15&pages=78-83&publication_year=2003&author=Pasiekal%2CJL?
• http://scholar.google.com/scholar_lookup?&title=AJCC%20Cancer%20Staging%20Manual&pages=1-646&publication_year=2010&author=Edge%2CS&author=Byrd%2CDR&author=Compton%2CCC&author=Fritz%2CAG&author=Greene%2CF&author=Trotti%2CA's financial summary
• What's the income of https://doi.org/10.1245%2FASO.2006.05.042?
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16474910 make?
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=Anaplastic%20thyroid%20carcinoma%3A%20Biology%2C%20pathogenesis%2C%20prognostic%20factors%2C%20and%20treatment%20approaches&journal=Ann.%20Surg.%20Oncol.&doi=10.1245%2FASO.2006.05.042&volume=13&pages=453-464&publication_year=2006&author=Are%2CC&author=Shaha%2CAR?
• How much does https://doi.org/10.1097%2FMOO.0b013e328343af3d generate monthly?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21252667's financial summary
• What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Anaplastic%20thyroid%20carcinoma%3A%20Palliation%20or%20treatment%3F&journal=Curr%20Opin%20Otolaryngol.%20Head.%20Neck.%20Surg.&doi=10.1097%2FMOO.0b013e328343af3d&volume=19&pages=113-118&publication_year=2011&author=Wein%2CRO&author=Weber%2CRS?
• Learn how profitable https://doi.org/10.6004%2Fjnccn.2015.0139 is on a monthly basis
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26358798
• How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986600 earn?
• How much does http://scholar.google.com/scholar_lookup?&title=Anaplastic%20tyroid%20carcinoma%2C%20Version%202.%202015&journal=J.%20Natl.%20Compr.%20Canc.%20Netw&doi=10.6004%2Fjnccn.2015.0139&volume=13&pages=1140-1150&publication_year=2015&author=Haddad%2CRI&author=Lydiatt%2CWM&author=Ball%2CDW&author=Busaidy%2CNL&author=Byrd%2CD&author=Callender%2CG&author=Dickson%2CP&author=Duh%2CQY&author=Ehya%2CH&author=Haymart%2CM&author=Hoh%2CC&author=Hunt%2CJP&author=Iagaru%2CA&author=Kandeel%2CF&author=Kopp%2CP&author=Lamonica%2CDM&author=McCaffrey%2CJC&author=Moley%2CJF&author=Parks%2CL&author=Raeburn%2CCD&author=Ridge%2CJA&author=Ringel%2CMD&author=Scheri%2CRP&author=Shah%2CJP&author=Smallridge%2CRC&author=Sturgeon%2CC&author=Wang%2CTN&author=Wirth%2CLJ&author=Hoffmann%2CKG&author=Hughes%2CM generate monthly?
• How much money does https://doi.org/10.1210%2Fjc.2014-2803 generate?
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25347569 make?
• How much does http://scholar.google.com/scholar_lookup?&title=Personalized%20therapy%20in%20patients%20with%20anaplastic%20thyroid%20cancer%3A%20Targeting%20genetic%20and%20epigenetic%20alterations&journal=J.%20Clin.%20Endocrinol.%20Metab.&doi=10.1210%2Fjc.2014-2803&volume=100&pages=35-42&publication_year=2015&author=Smith%2CN&author=Nucera%2CC earn?
• How much does https://doi.org/10.1210%2Fjc.2008-0273 earn?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18492751 make?
• http://scholar.google.com/scholar_lookup?&title=Highly%20prevalent%20genetic%20alterations%20in%20receptor%20tyrosine%20kinases%20and%20phosphatidylinositol%203-kinase%2Fakt%20and%20mitogen-activated%20protein%20kinase%20pathways%20in%20anaplastic%20and%20follicular%20thyroid%20cancers&journal=J.%20Clin.%20Endocrinol.%20Metab.&doi=10.1210%2Fjc.2008-0273&volume=93&pages=3106-3116&publication_year=2008&author=Liu%2CZ&author=Hou%2CP&author=Ji%2CM&author=Guan%2CH&author=Studeman%2CK&author=Jensen%2CK&author=Vasko%2CV&author=El-Naggar%2CAK&author=Xing%2CM income
• How much does https://doi.org/10.1016%2Fj.tibs.2011.03.006 pull in?
• Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21531565's earnings
• How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112285 rake in every month?
• Find out how much http://scholar.google.com/scholar_lookup?&title=The%20Ras-ERK%20and%20PI3K-mTOR%20pathways%3A%20Cross-talk%20and%20compensation&journal=Trends.%20Biochem.%20Sci.&doi=10.1016%2Fj.tibs.2011.03.006&volume=36&pages=320-328&publication_year=2011&author=Mendoza%2CMC&author=Er%2CEE&author=Blenis%2CJ earns monthly
• Find out how much https://doi.org/10.1016%2Fj.advenzreg.2006.01.004 earns monthly
• How much income does http://scholar.google.com/scholar_lookup?&title=Roles%20of%20the%20RAF%2FMEK%2FERK%20and%20PI3K%2FPTEN%2FAKT%20pathways%20in%20malignant%20transformation%20and%20drug%20resistance&journal=Adv.%20Enzym.%20Regul.&doi=10.1016%2Fj.advenzreg.2006.01.004&volume=46&pages=249-279&publication_year=2006&author=McCubrey%2CJA&author=Steelman%2CLS&author=Abrams%2CSL&author=Lee%2CJT&author=Chang%2CF&author=Bertrand%2CFE&author=Navolanic%2CPM&author=Terrian%2CDM&author=Franklin%2CRA&author=D%27Assoro%2CAB&author=Salisbury%2CJL&author=Mazzarino%2CMC&author=Stivala%2CF&author=Libra%2CM have?
• How much income is https://doi.org/10.1016%2Fj.trsl.2014.06.005 earning monthly?
• What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25016932?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Targeting%20RAS-MAPK-ERK%20and%20PI3K-AKT-mTOR%20signal%20transduction%20pathways%20to%20chemosensitize%20anaplastic%20thyroid%20carcinoma&journal=Transl.%20Res.&doi=10.1016%2Fj.trsl.2014.06.005&volume=164&pages=411-423&publication_year=2014&author=Milosevic%2CZ&author=Pesic%2CM&author=Stankovic%2CT&author=Dinic%2CJ&author=Milovanovic%2CZ&author=Stojsic%2CJ&author=Dzodic%2CR&author=Tanic%2CN&author=Bankovic%2CJ?
• Learn about the earnings of https://doi.org/10.1016%2Fj.ccr.2007.05.008
• What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17613433?
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=Defining%20the%20role%20of%20mTOR%20in%20cancer&journal=Cancer.%20Cell.&doi=10.1016%2Fj.ccr.2007.05.008&volume=12&pages=9-22&publication_year=2007&author=Guertin%2CDA&author=Sabatini%2CDM?
• How much does https://doi.org/10.1158%2F0008-5472.CAN-08-3014 pull in?
• What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19244117's gross income?
• How much income does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652681 have?
• What's the profit of http://scholar.google.com/scholar_lookup?&title=TORC-specific%20phosphorylation%20of%20mammalian%20target%20of%20rapamycin%20%28mTOR%29%3A%20Phospho-Ser2481%20is%20a%20marker%20for%20intact%20mTOR%20signaling%20complex%202&journal=Cancer.%20Res.&doi=10.1158%2F0008-5472.CAN-08-3014&volume=69&pages=1821-1827&publication_year=2009&author=Copp%2CJ&author=Manning%2CG&author=Hunter%2CT?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21541789 generate?
• See how much http://scholar.google.com/scholar_lookup?&title=Clinical%20activity%20of%20mammalian%20target%20of%20rapamycin%20inhibitors%20in%20solid%20tumors&journal=Target.%20Oncol.&doi=10.1007%2Fs11523-011-0178-5&volume=6&pages=69-94&publication_year=2011&author=Alvarado%2CY&author=Mita%2CMM&author=Vemulapalli%2CS&author=Mahalingam%2CD&author=Mita%2CAC makes per month
• How much does https://doi.org/10.1172%2FJCI44145 gross monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21490404 rake in every month?
• What's the revenue for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069769?
• http://scholar.google.com/scholar_lookup?&title=Next-generation%20mTOR%20inhibitors%20in%20clinical%20oncology%3A%20How%20pathway%20complexity%20informs%20therapeutic%20strategy&journal=J.%20Clin.%20Invest.&doi=10.1172%2FJCI44145&volume=121&pages=1231-1241&publication_year=2011&author=Wander%2CSA&author=Hennessy%2CBT&author=Slingerland%2CJM's revenue stream
• What's the income generated by https://doi.org/10.1111%2Fj.1365-2443.2010.01482.x each month?
• Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21210909's earnings
• Income figures for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116645
• How much does http://scholar.google.com/scholar_lookup?&title=Activating%20mutations%20of%20TOR%20%28target%20of%20rapamycin%29&journal=Genes.%20Cells.&doi=10.1111%2Fj.1365-2443.2010.01482.x&volume=16&pages=141-151&publication_year=2011&author=Hardt%2CM&author=Chantaravisoot%2CN&author=Tamanoi%2CF make?
• Income figures for https://doi.org/10.1016%2Fj.mce.2009.10.016
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19897009 produce monthly?
• Get to know http://scholar.google.com/scholar_lookup?&title=The%20PI3K-Akt-mTOR%20pathway%20in%20initiation%20and%20progression%20of%20thyroid%20tumors&journal=Mol.%20Cell.%20Endocrinol.&doi=10.1016%2Fj.mce.2009.10.016&volume=321&pages=20-28&publication_year=2010&author=Saji%2CM&author=Ringel%2CMD's earnings
• What's the total monthly financial gain of https://doi.org/10.1016%2Fj.ctrv.2015.06.005?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26138515's revenue stream
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=PI3K%2FAkt%2FmTOR%3A%20A%20promising%20therapeutic%20target%20for%20non-medullary%20thyroid%20carcinoma&journal=Cancer.%20Treat.%20Rev.&doi=10.1016%2Fj.ctrv.2015.06.005&volume=41&pages=707-713&publication_year=2015&author=Petrulea%2CMS&author=Plantinga%2CTS&author=Smit%2CJW&author=Georgescu%2CCE&author=Netea-Maier%2CRT?
• How much does https://doi.org/10.1002%2Fajh.24671 gross monthly?
• How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28211162?
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Efficacy%20of%20the%20oral%20mTORC1%20inhibitor%20everolimus%20in%20relapsed%20or%20refractory%20indolent%20lymphoma&journal=Am.%20J.%20Hematol&doi=10.1002%2Fajh.24671&volume=92&pages=448-453&publication_year=2017&author=Bennani%2CNN&author=LaPlant%2CBR&author=Ansell%2CSM&author=Habermann%2CTM&author=Inwards%2CDJ&author=Micallef%2CIN&author=Johnston%2CPB&author=Porrata%2CLF&author=Colgan%2CJP&author=Markovic%2CSN&author=Nowakowski%2CGS&author=Macon%2CWR&author=Reeder%2CCB&author=Mikhael%2CJR&author=Northfelt%2CDW&author=Ghobrial%2CIM&author=Witzig%2CTE is on a monthly basis
• Get to know https://doi.org/10.3892%2Fol.2016.5157's earnings
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27895779 is on a monthly basis
• How much profit is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104241 making per month?
• How much income does http://scholar.google.com/scholar_lookup?&title=Potential%20impact%20of%20mTOR%20inhibitors%20on%20cervical%20squamous%20cell%20carcinoma%3A%20A%20systematic%20review&journal=Oncol.%20Lett.&doi=10.3892%2Fol.2016.5157&volume=12&pages=4107-4116&publication_year=2016&author=Assad%2CDX&author=Elias%2CST&author=Melo%2CAC&author=Ferreira%2CCG&author=Luca%20Canto%2CG&author=Guerra%2CEN have?
• https://doi.org/10.1038%2Fnrm3025's total income per month
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21157483's total income per month
• How much revenue does http://scholar.google.com/scholar_lookup?&title=mTOR%3A%20From%20growth%20signal%20integration%20to%20cancer%2C%20diabetes%20and%20ageing&journal=Nat.%20Rev.%20Mol.%20Cell.%20Biol.&doi=10.1038%2Fnrm3025&volume=12&pages=21-35&publication_year=2011&author=Zoncu%2CR&author=Efeyan%2CA&author=Sabatini%2CDM produce monthly?
• Monthly income for https://doi.org/10.1158%2F0008-5472.CAN-09-0299
• How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19584280 making per month?
• Get to know http://scholar.google.com/scholar_lookup?&title=Biochemical%2C%20cellular%2C%20and%20in%20vivo%20activity%20of%20novel%20ATP-competitive%20and%20selective%20inhibitors%20of%20the%20mammalian%20target%20of%20rapamycin&journal=Cancer.%20Res.&doi=10.1158%2F0008-5472.CAN-09-0299&volume=69&pages=6232-6240&publication_year=2009&author=Yu%2CK&author=Toral-Barza%2CL&author=Shi%2CC&author=Zhang%2CWG&author=Lucas%2CJ&author=Shor%2CB&author=Kim%2CJ&author=Verheijen%2CJ&author=Curran%2CK&author=Malwitz%2CDJ&author=Cole%2CDC&author=Ellingboe%2CJ&author=Ayral-Kaloustian%2CS&author=Mansour%2CTS&author=Gibbons%2CJJ&author=Abraham%2CRT&author=Nowak%2CP&author=Zask%2CA's earnings
• How much does https://doi.org/10.1016%2Fj.eururo.2015.08.035 gross monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26364551 net monthly?
• Income figures for http://scholar.google.com/scholar_lookup?&title=A%20randomised%20phase%202%20study%20of%20AZD2014%20versus%20Everolimus%20in%20patients%20with%20VEGF-refractory%20metastatic%20clear%20cell%20renal%20Cancer&journal=Eur.%20Urol.&doi=10.1016%2Fj.eururo.2015.08.035&volume=69&pages=450-456&publication_year=2016&author=Powles%2CT&author=Wheater%2CM&author=Din%2CO&author=Geldart%2CT&author=Boleti%2CE&author=Stockdale%2CA&author=Sundar%2CS&author=Robinson%2CA&author=Ahmed%2CI&author=Wimalasingham%2CA&author=Burke%2CW&author=Sarker%2CSJ&author=Hussain%2CS&author=Ralph%2CC
• How much revenue does https://doi.org/10.1158%2F1535-7163.MCT-15-0365 bring in?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26358751 net monthly?
• How much profit does http://scholar.google.com/scholar_lookup?&title=AZD2014%2C%20an%20inhibitor%20of%20mTORC1%20and%20mTORC2%2C%20is%20highly%20effective%20in%20ER%2B%20breast%20Cancer%20when%20administered%20using%20intermittent%20or%20continuous%20schedules&journal=Mol.%20Cancer%20Ther.&doi=10.1158%2F1535-7163.MCT-15-0365&volume=14&pages=2508-2518&publication_year=2015&author=Guichard%2CSM&author=Curwen%2CJ&author=Bihani%2CT&author=D%27Cruz%2CCM&author=Yates%2CJW&author=Grondine%2CM&author=Howard%2CZ&author=Davies%2CBR&author=Bigley%2CG&author=Klinowska%2CT&author=Pike%2CKG&author=Pass%2CM&author=Chresta%2CCM&author=Polanska%2CUM&author=McEwen%2CR&author=Delpuech%2CO&author=Green%2CS&author=Cosulich%2CSC make?
• How much profit does https://doi.org/10.1038%2Fsj.onc.1206938 generate?
• Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14576842
• How much does http://scholar.google.com/scholar_lookup?&title=Multidrug%20resistance%20mediated%20by%20the%20breast%20cancer%20resistance%20protein%20BCRP%20%28ABCG2%29&journal=Oncogene&doi=10.1038%2Fsj.onc.1206938&volume=22&pages=7340-7358&publication_year=2003&author=Doyle%2CL&author=Ross%2CDD bring in each month?
• How profitable is https://doi.org/10.1016%2F0005-2736%2876%2990160-7?
• Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=990323
• Profit of http://scholar.google.com/scholar_lookup?&title=A%20surface%20glycoprotein%20modulating%20drug%20permeability%20in%20Chinese%20hamster%20ovary%20cell%20mutants&journal=Biochim.%20Biophys.%20Acta&doi=10.1016%2F0005-2736%2876%2990160-7&volume=455&pages=152-162&publication_year=1976&author=Juliano%2CRL&author=Ling%2CV
• How much income does https://doi.org/10.1016%2Fj.febslet.2005.12.060 have?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16405967 make?
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=The%20molecular%20basis%20of%20multidrug%20resistance%20in%20cancer%3A%20The%20early%20years%20of%20P-glycoprotein%20research&journal=FEBS.%20Lett.&doi=10.1016%2Fj.febslet.2005.12.060&volume=580&pages=998-1009&publication_year=2006&author=Gottesman%2CMM&author=Ling%2CV?
• How much does https://doi.org/10.1152%2Fphysrev.00035.2005 gross monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16816140 net monthly?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Transmembrane%20transport%20of%20endo-%20and%20xenobiotics%20by%20mammalian%20ATP-binding%20cassette%20multidrug%20resistance%20proteins&journal=Physiol.%20Rev.&doi=10.1152%2Fphysrev.00035.2005&volume=86&pages=849-899&publication_year=2006&author=Deeley%2CRG&author=Westlake%2CC&author=Cole%2CSP bring in?
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16362298?
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Multidrug%20resistance%20proteins%20and%20folate%20supplementation%3A%20Therapeutic%20implications%20for%20antifolates%20and%20other%20classes%20of%20drugs%20in%20cancer%20treatment&journal=Cancer%20Chemother.%20Pharmacol.&doi=10.1007%2Fs00280-005-0141-1&volume=58&pages=1-12&publication_year=2006&author=Hooijberg%2CJH&author=Vries%2CNA&author=Kaspers%2CGJ&author=Pieters%2CR&author=Jansen%2CG&author=Peters%2CGJ?
• How much does https://doi.org/10.1152%2Fphysrev.00037.2005 make?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17015488 bring in?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Human%20multidrug%20resistance%20ABCB%20and%20ABCG%20transporters%3A%20Participation%20in%20a%20chemoimmunity%20defense%20system&journal=Physiol.%20Rev.&doi=10.1152%2Fphysrev.00037.2005&volume=86&pages=1179-1236&publication_year=2006&author=Sarkadi%2CB&author=Homolya%2CL&author=Szakacs%2CG&author=Varadi%2CA?
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12879476 is on a monthly basis
• See how much http://scholar.google.com/scholar_lookup?&title=The%20association%20of%20P-glycoprotein%20with%20response%20to%20chemotherapy%20and%20clinical%20outcome%20in%20patients%20with%20osteosarcoma&journal=A%20meta-analysis%20Cancer&volume=98&pages=581-589&publication_year=2003&author=Pakos%2CEE&author=Ioannidis%2CJP makes per month
• What's the financial outcome of https://doi.org/10.1038%2Fsj.bjc.6600803?
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12644825?
• See how much http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377094 makes per month
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Lung%20resistance-related%20protein%20as%20a%20predictor%20of%20clinical%20outcome%20in%20advanced%20testicular%20germ-cell%20tumours&journal=Br.%20J.%20Cancer&doi=10.1038%2Fsj.bjc.6600803&volume=88&pages=879-886&publication_year=2003&author=Zurita%2CAJ&author=Diestra%2CJE&author=Condom%2CE&author=Garcia%20Del%20Muro%2CX&author=Scheffer%2CGL&author=Scheper%2CRJ&author=Perez%2CJ&author=Germa-Lluch%2CJR&author=Izquierdo%2CMA?
• How much revenue does https://doi.org/10.1016%2F0065-2571%2884%2990007-4 generate?
• Income figures for http://scholar.google.com/scholar_lookup?&title=Quantitative%20analysis%20of%20dose-effect%20relationships%3A%20The%20combined%20effects%20of%20multiple%20drugs%20or%20enzyme%20inhibitors&journal=Adv.%20Enzym.%20Regul.&doi=10.1016%2F0065-2571%2884%2990007-4&volume=22&pages=27-55&publication_year=1984&author=Chou%2CTC&author=Talalay%2CP
• How much revenue does https://doi.org/10.1093%2Fcarcin%2Fbgi045 produce monthly?
• How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15760920 making per month?
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Induction%20of%20DMBT1%20expression%20by%20reduced%20ERK%20activity%20during%20a%20gastric%20mucosa%20differentiation-like%20process%20and%20its%20association%20with%20human%20gastric%20cancer&journal=Carcinogenesis&doi=10.1093%2Fcarcin%2Fbgi045&volume=26&pages=1129-1137&publication_year=2005&author=Kang%2CW&author=Nielsen%2CO&author=Fenger%2CC&author=Leslie%2CG&author=Holmskov%2CU&author=Reid%2CKB
• Get to know https://doi.org/10.1016%2Fj.ejphar.2011.04.065's earnings
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21620827 bring in?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=The%20labdane%20diterpene%20sclareol%20%28labd-14-ene-8%2C%2013-diol%29%20induces%20apoptosis%20in%20human%20tumor%20cell%20lines%20and%20suppression%20of%20tumor%20growth%20in%20vivo%20via%20a%20p53-independent%20mechanism%20of%20action&journal=Eur.%20J.%20Pharmacol.&doi=10.1016%2Fj.ejphar.2011.04.065&volume=666&pages=173-182&publication_year=2011&author=Mahaira%2CLG&author=Tsimplouli%2CC&author=Sakellaridis%2CN&author=Alevizopoulos%2CK&author=Demetzos%2CC&author=Han%2CZ&author=Pantazis%2CP&author=Dimas%2CK have monthly?
• https://doi.org/10.1155%2F2011%2F542358's financial summary
• Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21772843
• How much income does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136148 have?
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Anaplastic%20thyroid%20cancer%3A%20A%20review%20of%20epidemiology%2C%20pathogenesis%2C%20and%20treatment&journal=J.%20Oncol.&doi=10.1155%2F2011%2F542358&volume=2011&publication_year=2011&author=Nagaiah%2CG&author=Hossain%2CA&author=Mooney%2CCJ&author=Parmentier%2CJ&author=Remick%2CSC?
• https://doi.org/10.1016%2Fj.bbapap.2009.02.014's revenue stream
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19285158
• What are the total earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810319?
• How much does http://scholar.google.com/scholar_lookup?&title=A%20synonymous%20polymorphism%20in%20a%20common%20MDR1%20%28ABCB1%29%20haplotype%20shapes%20protein%20function&journal=Biochim.%20Biophys.%20Acta&doi=10.1016%2Fj.bbapap.2009.02.014&volume=1794&pages=860-871&publication_year=2009&author=Fung%2CKL&author=Gottesman%2CMM generate monthly?
• How much does https://doi.org/10.1136%2Fjclinpath-2013-201711 make?
• What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23986551?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Expression%20of%20cancer%20stem%20cell%20markers%20is%20more%20frequent%20in%20anaplastic%20thyroid%20carcinoma%20compared%20to%20papillary%20thyroid%20carcinoma%20and%20is%20related%20to%20adverse%20clinical%20outcome&journal=J.%20Clin.%20Pathol.&doi=10.1136%2Fjclinpath-2013-201711&volume=67&pages=125-133&publication_year=2014&author=Yun%2CJY&author=Kim%2CYA&author=Choe%2CJY&author=Min%2CH&author=Lee%2CKS&author=Jung%2CY&author=Oh%2CS&author=Kim%2CJE make?
• How much does https://doi.org/10.3892%2Fijo_00000746 pull in?
• What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20596658 each month?
• Find out how much http://scholar.google.com/scholar_lookup?&title=Doxorubicin%20fails%20to%20eradicate%20cancer%20stem%20cells%20derived%20from%20anaplastic%20thyroid%20carcinoma%20cells%3A%20Characterization%20of%20resistant%20cells&journal=Int.%20J.%20Oncol.&doi=10.3892%2Fijo_00000746&volume=37&pages=307-315&publication_year=2010&author=Zheng%2CX&author=Cui%2CD&author=Xu%2CS&author=Brabant%2CG&author=Derwahl%2CM earns monthly
• Income figures for https://doi.org/10.1089%2Fthy.2012.0372
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23301671 produce monthly?
• How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704189 make?
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Multiple%20pluripotent%20stem%20cell%20markers%20in%20human%20anaplastic%20thyroid%20cancer%3A%20The%20putative%20upstream%20role%20of%20SOX2&journal=Thyroid&doi=10.1089%2Fthy.2012.0372&volume=23&pages=829-837&publication_year=2013&author=Carina%2CV&author=Zito%2CG&author=Pizzolanti%2CG&author=Richiusa%2CP&author=Criscimanna%2CA&author=Rodolico%2CV&author=Tomasello%2CL&author=Pitrone%2CM&author=Arancio%2CW&author=Giordano%2CC
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28137290
• How profitable is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282816?
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=The%20role%20of%20autophagy%20in%20the%20cross-talk%20between%20epithelial-mesenchymal%20transitioned%20tumor%20cells%20and%20cancer%20stem-like%20cells&journal=Mol.%20Cancer&doi=10.1186%2Fs12943-016-0573-8&volume=16&publication_year=2017&author=Marcucci%2CF&author=Ghezzi%2CP&author=Rumio%2CC
• Revenue of https://doi.org/10.1016%2Fj.acthis.2011.11.004
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22154301 earn?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=MDR-1-overexpression%20in%20HT%2029%20colon%20cancer%20cells%20grown%20in%20SCID%20mice&journal=Acta%20Histochem.&doi=10.1016%2Fj.acthis.2011.11.004&volume=114&pages=594-602&publication_year=2012&author=Schumacher%2CU&author=Nehmann%2CN&author=Adam%2CE&author=Mukthar%2CD&author=Slotki%2CIN&author=Horny%2CHP&author=Flens%2CMJ&author=Schlegelberger%2CB&author=Steinemann%2CD
• Explore the financials of https://doi.org/10.1038%2Fnrc2803
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20147901 is on a monthly basis
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=Microtubules%20and%20resistance%20to%20tubulin-binding%20agents&journal=Nat.%20Rev.%20Cancer&doi=10.1038%2Fnrc2803&volume=10&pages=194-204&publication_year=2010&author=Kavallaris%2CM?
• How much does https://doi.org/10.2217%2Fnnm-2016-0147 rake in every month?
• What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27226714?
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863683's revenue stream
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Synergistic%20inhibition%20of%20colon%20cancer%20cell%20growth%20with%20nanoemulsion-loaded%20paclitaxel%20and%20PI3K%2FmTOR%20dual%20inhibitor%20BEZ235%20through%20apoptosis&journal=Int.%20J.%20Nanomedicine&doi=10.2217%2Fnnm-2016-0147&volume=11&pages=1947-1958&publication_year=2016&author=Zou%2CH&author=Li%2CL&author=Garcia%20Carcedo%2CI&author=Xu%2CZP&author=Monteiro%2CM&author=Gu%2CW?
• https://doi.org/10.1093%2Fcarcin%2Fbgq059 income
• What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20299527?
• Get to know what's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893796
• What's the income of http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20mTORC1%20signaling%20reduces%20tumor%20growth%20but%20does%20not%20prevent%20cancer%20progression%20in%20a%20mouse%20model%20of%20thyroid%20cancer&journal=Carcinogenesis&doi=10.1093%2Fcarcin%2Fbgq059&volume=31&pages=1284-1291&publication_year=2010&author=Guigon%2CCJ&author=Fozzatti%2CL&author=Lu%2CC&author=Willingham%2CMC&author=Cheng%2CSY?
• https://doi.org/10.1023%2FA%3A1008322002520's financial summary
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11061600 earn?
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Anaplastic%20thyroid%20carcinoma%3A%20Current%20diagnosis%20and%20treatment&journal=Ann.%20Oncol.&doi=10.1023%2FA%3A1008322002520&volume=11&pages=1083-1089&publication_year=2000&author=Giuffrida%2CD&author=Gharib%2CH is on a monthly basis
• What's the income of https://doi.org/10.1242%2Fjcs.023333?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18287584 bring in each month?
• How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671295 gross monthly?
• How much profit does http://scholar.google.com/scholar_lookup?&title=The%20regulation%20of%20cell%20motility%20and%20chemotaxis%20by%20phospholipid%20signaling&journal=J.%20Cell.%20Sci.&doi=10.1242%2Fjcs.023333&volume=121&pages=551-559&publication_year=2008&author=Kolsch%2CV&author=Charest%2CPG&author=Firtel%2CRA make?
• What's the monthly money flow for https://doi.org/10.1016%2Fj.febslet.2008.04.039?
• How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18460342 have monthly?
• How profitable is http://scholar.google.com/scholar_lookup?&title=Rho%20GTPases%20in%20cancer%20cell%20biology&journal=FEBS%20Lett.&doi=10.1016%2Fj.febslet.2008.04.039&volume=582&pages=2093-2101&publication_year=2008&author=Vega%2CFM&author=Ridley%2CAJ?
• How much revenue does https://doi.org/10.1158%2F0008-5472.CAN-10-4058 bring in?
• Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21430067
• What are the total earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085654?
• http://scholar.google.com/scholar_lookup?&title=mTORC1%20and%20mTORC2%20regulate%20EMT%2C%20motility%2C%20and%20metastasis%20of%20colorectal%20cancer%20via%20RhoA%20and%20Rac1%20signaling%20pathways&journal=Cancer.%20Res.&doi=10.1158%2F0008-5472.CAN-10-4058&volume=71&pages=3246-3256&publication_year=2011&author=Gulhati%2CP&author=Bowen%2CKA&author=Liu%2CJ&author=Stevens%2CPD&author=Rychahou%2CPG&author=Chen%2CM&author=Lee%2CEY&author=Weiss%2CHL&author=O%27Connor%2CKL&author=Gao%2CT&author=Evers%2CBM income
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25628925 produce monthly?
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=Dramatic%20antitumor%20effects%20of%20the%20dual%20mTORC1%20and%20mTORC2%20inhibitor%20AZD2014%20in%20hepatocellular%20carcinoma&journal=Am.%20J.%20Cancer%20Res.&volume=5&pages=125-139&publication_year=2015&author=Liao%2CH&author=Huang%2CY&author=Guo%2CB&author=Liang%2CB&author=Liu%2CX&author=Ou%2CH&author=Jiang%2CC&author=Li%2CX&author=Yang%2CD each month?
• How much cash flow does https://doi.org/10.1016%2Fj.bmcl.2013.01.019 have monthly?
• What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23375793?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Optimization%20of%20potent%20and%20selective%20dual%20mTORC1%20and%20mTORC2%20inhibitors%3A%20The%20discovery%20of%20AZD8055%20and%20AZD2014&journal=Bioorg.%20Med.%20Chem.%20Lett.&doi=10.1016%2Fj.bmcl.2013.01.019&volume=23&pages=1212-1216&publication_year=2013&author=Pike%2CKG&author=Malagu%2CK&author=Hummersone%2CMG&author=Menear%2CKA&author=Duggan%2CHM&author=Gomez%2CS&author=Martin%2CNM&author=Ruston%2CL&author=Pass%2CSL&author=Pass%2CM have monthly?
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19688827
• How much profit is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818608 making per month?
• What's the income of http://scholar.google.com/scholar_lookup?&title=Rapamycin%20potentiates%20the%20effects%20of%20paclitaxel%20in%20endometrial%20cancer%20cells%20through%20inhibition%20of%20cell%20proliferation%20and%20induction%20of%20apoptosis&journal=Int.%20J.%20Cancer&volume=126&pages=1144-1154&publication_year=2010&author=Shafer%2CA&author=Zhou%2CC&author=Gehrig%2CPA&author=Boggess%2CJF&author=Bae-Jump%2CVL?
• How profitable is https://doi.org/10.1038%2Fsj.onc.1206175?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12555062's revenue stream
• How much income is http://scholar.google.com/scholar_lookup?&title=Paclitaxel%20induces%20inactivation%20of%20p70%20S6%20kinase%20and%20phosphorylation%20of%20Thr421%20and%20Ser424%20via%20multiple%20signaling%20pathways%20in%20mitosis&journal=Oncogene&doi=10.1038%2Fsj.onc.1206175&volume=22&pages=484-497&publication_year=2003&author=Le%2CXF&author=Hittelman%2CWN&author=Liu%2CJ&author=McWatters%2CA&author=Li%2CC&author=Mills%2CGB&author=Bast%2CRC earning monthly?
• Learn how profitable https://doi.org/10.1517%2F14728222.2012.684680 is on a monthly basis
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22564017 earn?
• How much does http://scholar.google.com/scholar_lookup?&title=Exploiting%20p70%20S6%20kinase%20as%20a%20target%20for%20ovarian%20cancer&journal=Expert.%20Opin.%20Ther.%20Targets&doi=10.1517%2F14728222.2012.684680&volume=16&pages=619-630&publication_year=2012&author=Ip%2CCK&author=Wong%2CAS make?
• Check the income stats for http://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-azd2014-with-paclitaxel-for-solid-tumours-tax-torc
• What's https://citation-needed.springer.com/v2/references/10.1007/s13402-018-0380-x?format=refman&flavour=references's gross income?
• Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Zorica%20Milo%C5%A1evi%C4%87
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Zorica%20Milo%C5%A1evi%C4%87%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jasna%20Bankovi%C4%87's revenue stream
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jasna%20Bankovi%C4%87%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
• Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jelena%20Dini%C4%87
• Find out how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jelena%20Dini%C4%87%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earns monthly
• Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Chrisiida%20Tsimplouli
• Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Chrisiida%20Tsimplouli%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Evangelia%20Sereti net monthly?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Evangelia%20Sereti%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
• What's the total monthly financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Miodrag%20Dragoj?
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Miodrag%20Dragoj%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Verica%20Paunovi%C4%87 generate?
• What's the financial outcome of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Verica%20Paunovi%C4%87%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Zorka%20Milovanovi%C4%87 have?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Zorka%20Milovanovi%C4%87%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
• Learn how profitable https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Marija%20Stepanovi%C4%87 is on a monthly basis
• How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Marija%20Stepanovi%C4%87%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
• Monthly income for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Nikola%20Tani%C4%87
• What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Nikola%20Tani%C4%87%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kostantinos%20Dimas make?
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kostantinos%20Dimas%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Milica%20Pe%C5%A1i%C4%87's revenue stream
• Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Milica%20Pe%C5%A1i%C4%87%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Find out how much https://static-content.springer.com/esm/art%3A10.1007%2Fs13402-018-0380-x/MediaObjects/13402_2018_380_MOESM1_ESM.pdf earns monthly
• How much does https://s100.copyright.com/AppDispatchServlet?title=Potential%20of%20the%20dual%20mTOR%20kinase%20inhibitor%20AZD2014%20to%20overcome%20paclitaxel%20resistance%20in%20anaplastic%20thyroid%20carcinoma&author=Zorica%20Milo%C5%A1evi%C4%87%20et%20al&contentID=10.1007%2Fs13402-018-0380-x©right=International%20Society%20for%20Cellular%20Oncology&publication=2211-3428&publicationDate=2018-05-22&publisherName=SpringerNature&orderBeanReset=true rake in every month?
• Get to know https://crossmark.crossref.org/dialog/?doi=10.1007/s13402-018-0380-x's earnings
• What's the income generated by https://citation-needed.springer.com/v2/references/10.1007/s13402-018-0380-x?format=refman&flavour=citation each month?
• What's the income of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral?
• What's the income generated by https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research each month?
• What's the income of https://www.springernature.com/gp/products?
• Learn how profitable https://www.springernature.com/gp/librarians is on a monthly basis
• How much does https://www.springernature.com/gp/societies gross monthly?
• Check the income stats for https://www.springernature.com/gp/partners
• Monthly income for https://www.springer.com/
• Explore the financials of https://www.nature.com/
• What's the financial gain of https://www.biomedcentral.com/?
• What's the income generated by https://www.palgrave.com/ each month?
• How much does https://www.apress.com/ pull in monthly?
• Revenue of https://www.springernature.com/gp/legal/ccpa
• https://www.springernature.com/gp/info/accessibility income
• Profit of https://support.springernature.com/en/support/home
• How much does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations generate monthly?
• Learn how profitable https://www.springernature.com/ is on a monthly basis

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

CDN Services {📦}

• Crossref